Medical Research
Study identifies SLAMF6 as a self-activating brake on anti-cancer T cells, pointing to a new immunotherapy target
Reported by AI Image generated by AI Fact checked
A research team led by Université de Montréal immunologist André Veillette reports that the immune receptor SLAMF6 can inhibit T cells by activating through interactions on the T cell surface itself, a mechanism the authors say could help explain why some patients fail to respond—or later stop responding—to checkpoint-based cancer immunotherapies. In the same study, the researchers describe monoclonal antibodies designed to block SLAMF6’s self-interaction, which boosted T-cell activity in laboratory tests and strengthened anti-tumor responses in mouse experiments.
A copper-based drug has shown potential to reduce toxic protein buildup and improve memory in laboratory models of Alzheimer’s disease. Researchers at Monash University found that the compound Cu(ATSM) enhanced the brain’s waste-clearing mechanisms. The results were published in ACS Chemical Neuroscience.
Reported by AI
Chess featured prominently at a clinical symposium on Brain-Computer Interface technology held in Shenzhen. FIDE Treasurer Zhu Chen attended the event, highlighting the game's potential in advancing medical research.
A study of 440 participants from the Women’s Interagency HIV Study found that accelerated epigenetic aging in monocytes—an immune cell type—tracked more closely with emotional and cognitive depression symptoms such as hopelessness and loss of pleasure than with physical symptoms like fatigue. The work, published in The Journals of Gerontology: Series A, adds evidence that cell-type-specific aging measures could contribute to future biological tools to complement symptom-based depression screening, though researchers say more validation is needed before clinical use.
Reported by AI Fact checked
Engineers at Washington University in St. Louis report that while single abnormal cells can mechanically probe roughly 10 microns beyond what they directly touch, groups of epithelial cells can combine forces through collagen to sense features more than 100 microns away—an effect the researchers say could help explain how cancer cells navigate tissue.
A study shows that advanced lung cancer patients receiving immunochemotherapy earlier in the day survive longer. A Hong Kong medical expert says the discovery opens possibilities for optimal treatment times, though more research is needed. The research was led by academics from Hunan Cancer Hospital in mainland China and supported by the Chinese University of Hong Kong’s faculty of medicine.
Reported by AI
Researchers in Brazil have uncovered how pancreatic cancer uses a protein called periostin to invade nerves and spread early. This discovery explains the disease's aggressiveness and suggests new treatment targets. The findings, published in Molecular and Cellular Endocrinology, highlight the tumor's ability to remodel surrounding tissue.
Researchers test electricity-based method to reshape the cornea for vision correction
May 28, 2026 21:50Penn researchers identify immune protein GPNMB as potential target to slow Parkinson’s-related pathology spread
May 20, 2026 20:53Study finds alzheimer's risk factors hit women harder
May 17, 2026 23:35Scientists find MYC protein helps cancers resist chemotherapy
May 16, 2026 23:05Hidden tooth-root infections may be linked to poorer blood sugar control, studies suggest
March 13, 2026 04:30Study links dual colon polyps to higher risk of advanced precancerous changes
March 08, 2026 06:38PET brain scans link ketamine’s rapid antidepressant effect to shifts in AMPA receptor availability
February 25, 2026 03:13UCLA study finds five-day accelerated TMS schedule performed similarly to conventional six-week course for treatment-resistant depression
February 24, 2026 06:42Study links brain blood flow changes to Alzheimer's risk
February 15, 2026 20:58Study links sympathetic nerve signaling to early pancreatic cancer growth via a fibroblast feedback loop